American Biogenetic Sciences, Inc.
Records under this name other than patents American Biogenetic Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to American Biogenetic Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE37,670 | Antiproliferative and neurotrophic molecules Formerly held Term ended Term ended Aug 30, 2014 · From the USPTO record | Term ended | Term ended Aug 30, 2014 | From the USPTO record |
| US 6,274,624 | Antiproliferative and neurotrophic molecules Formerly held Lapsed on the fee record Ended Aug 14, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2013 | From the USPTO record |
| US 6,187,593 | Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein Lapsed on the fee record Ended Feb 13, 2013 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2013 | From the USPTO record |
| US 6,300,373 | Antiproliferative and neurotrophic molecules Formerly held Lapsed on the fee record Ended Oct 9, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2009 | From the USPTO record |
| US 6,294,173 | Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein Lapsed on the fee record Ended Sep 25, 2009 · From the USPTO record | Lapsed on the fee record | Ended Sep 25, 2009 | From the USPTO record |
| US 6,458,840 | Use of valproic acid analog for the treatment and prevention of migraine and affective illness Lapsed on the fee record Ended Oct 1, 2006 · From the USPTO record | Lapsed on the fee record | Ended Oct 1, 2006 | From the USPTO record |
| US 6,436,954 | Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof Lapsed on the fee record Ended Aug 20, 2006 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2006 | From the USPTO record |
| US 6,268,396 | Use of valproic acid analog for the treatment and prevention of migraine and affective illness Lapsed on the fee record Ended Jul 31, 2005 · From the USPTO record | Lapsed on the fee record | Ended Jul 31, 2005 | From the USPTO record |
| US 6,184,401 | Alpha-fluoro alkynoic acids with anticonvulsant activity Lapsed on the fee record Ended Feb 6, 2005 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2005 | From the USPTO record |
| US 6,080,384 | Methods for radionuclide-labeling of biomolecules and kits utilizing the same Lapsed on the fee record Ended Jun 27, 2004 · From the USPTO record | Lapsed on the fee record | Ended Jun 27, 2004 | From the USPTO record |